# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-26-228133
Filing Date
2026-05-18
Accepted
2026-05-18 09:33:34
Documents
56
Period of Report
2026-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d109149d8k.htm iXBRL | 8-K | 80200
2 | EX-2.1 | d109149dex21.htm | EX-2.1 | 642927
3 | EX-3.1 | d109149dex31.htm | EX-3.1 | 81558
4 | EX-4.1 | d109149dex41.htm | EX-4.1 | 96800
5 | EX-10.1 | d109149dex101.htm | EX-10.1 | 209232
6 | EX-10.2 | d109149dex102.htm | EX-10.2 | 89627
7 | EX-10.3 | d109149dex103.htm | EX-10.3 | 9328
8 | EX-10.4 | d109149dex104.htm | EX-10.4 | 31990
9 | EX-10.5 | d109149dex105.htm | EX-10.5 | 3673
10 | EX-10.6 | d109149dex106.htm | EX-10.6 | 3692
11 | EX-99.1 | d109149dex991.htm | EX-99.1 | 28260
12 | EX-99.2 | d109149dex992.htm | EX-99.2 | 26913
13 | EX-99.3 | d109149dex993.htm | EX-99.3 | 43751
17 | GRAPHIC | g109149ex99_3s10g1.jpg | GRAPHIC | 77992
18 | GRAPHIC | g109149ex99_3s11g1.jpg | GRAPHIC | 86281
19 | GRAPHIC | g109149ex99_3s12g1.jpg | GRAPHIC | 88931
20 | GRAPHIC | g109149ex99_3s13g1.jpg | GRAPHIC | 97570
21 | GRAPHIC | g109149ex99_3s14g1.jpg | GRAPHIC | 91321
22 | GRAPHIC | g109149ex99_3s15g1.jpg | GRAPHIC | 98174
23 | GRAPHIC | g109149ex99_3s16g1.jpg | GRAPHIC | 115968
24 | GRAPHIC | g109149ex99_3s17g1.jpg | GRAPHIC | 101560
25 | GRAPHIC | g109149ex99_3s18g1.jpg | GRAPHIC | 91241
26 | GRAPHIC | g109149ex99_3s19g1.jpg | GRAPHIC | 72831
27 | GRAPHIC | g109149ex99_3s1g1.jpg | GRAPHIC | 70952
28 | GRAPHIC | g109149ex99_3s20g1.jpg | GRAPHIC | 91115
29 | GRAPHIC | g109149ex99_3s21g1.jpg | GRAPHIC | 102522
30 | GRAPHIC | g109149ex99_3s22g1.jpg | GRAPHIC | 75921
31 | GRAPHIC | g109149ex99_3s23g1.jpg | GRAPHIC | 74686
32 | GRAPHIC | g109149ex99_3s24g1.jpg | GRAPHIC | 64303
33 | GRAPHIC | g109149ex99_3s25g1.jpg | GRAPHIC | 74010
34 | GRAPHIC | g109149ex99_3s26g1.jpg | GRAPHIC | 94161
35 | GRAPHIC | g109149ex99_3s27g1.jpg | GRAPHIC | 130617
36 | GRAPHIC | g109149ex99_3s28g1.jpg | GRAPHIC | 71486
37 | GRAPHIC | g109149ex99_3s29g1.jpg | GRAPHIC | 97562
38 | GRAPHIC | g109149ex99_3s2g1.jpg | GRAPHIC | 280680
39 | GRAPHIC | g109149ex99_3s30g1.jpg | GRAPHIC | 62169
40 | GRAPHIC | g109149ex99_3s31g1.jpg | GRAPHIC | 49345
41 | GRAPHIC | g109149ex99_3s32g1.jpg | GRAPHIC | 52068
42 | GRAPHIC | g109149ex99_3s3g1.jpg | GRAPHIC | 170085
43 | GRAPHIC | g109149ex99_3s4g1.jpg | GRAPHIC | 115894
44 | GRAPHIC | g109149ex99_3s5g1.jpg | GRAPHIC | 130093
45 | GRAPHIC | g109149ex99_3s6g1.jpg | GRAPHIC | 56945
46 | GRAPHIC | g109149ex99_3s7g1.jpg | GRAPHIC | 108450
47 | GRAPHIC | g109149ex99_3s8g1.jpg | GRAPHIC | 119512
48 | GRAPHIC | g109149ex99_3s9g1.jpg | GRAPHIC | 102241
49 | GRAPHIC | g109149g0517022233005.jpg | GRAPHIC | 7522
| Complete submission text file | 0001193125-26-228133.txt |  | 6136170

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL TAXONOMY EXTENSION SCHEMA | qncx-20260517.xsd | EX-101.SCH | 3181
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | qncx-20260517_lab.xml | EX-101.LAB | 18738
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | qncx-20260517_pre.xml | EX-101.PRE | 11708
59 | EXTRACTED XBRL INSTANCE DOCUMENT | d109149d8k_htm.xml | XML | 3860

Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

EIN.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38890 | Film No.: 26991089
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)